These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 17979152)

  • 1. Predicting accrual in clinical trials with Bayesian posterior predictive distributions.
    Gajewski BJ; Simon SD; Carlson SE
    Stat Med; 2008 Jun; 27(13):2328-40. PubMed ID: 17979152
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Accrual Prediction Program: A web-based clinical trials tool for monitoring and predicting accrual for early-phase cancer studies.
    Liu J; Wick JA; Mudaranthakam DP; Jiang Y; Mayo MS; Gajewski BJ
    Clin Trials; 2019 Dec; 16(6):657-664. PubMed ID: 31451012
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bayesian accrual modeling and prediction in multicenter clinical trials with varying center activation times.
    Liu J; Wick J; Jiang Y; Mayo M; Gajewski B
    Pharm Stat; 2020 Sep; 19(5):692-709. PubMed ID: 32319194
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Building efficient comparative effectiveness trials through adaptive designs, utility functions, and accrual rate optimization: finding the sweet spot.
    Gajewski BJ; Berry SM; Quintana M; Pasnoor M; Dimachkie M; Herbelin L; Barohn R
    Stat Med; 2015 Mar; 34(7):1134-49. PubMed ID: 25640114
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modeling and validating Bayesian accrual models on clinical data and simulations using adaptive priors.
    Jiang Y; Simon S; Mayo MS; Gajewski BJ
    Stat Med; 2015 Feb; 34(4):613-29. PubMed ID: 25376910
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bayesian accrual prediction for interim review of clinical studies: open source R package and smartphone application.
    Jiang Y; Guarino P; Ma S; Simon S; Mayo MS; Raghavan R; Gajewski BJ
    Trials; 2016 Jul; 17(1):336. PubMed ID: 27449769
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bayesian modeling and prediction of accrual in multi-regional clinical trials.
    Deng Y; Zhang X; Long Q
    Stat Methods Med Res; 2017 Apr; 26(2):752-765. PubMed ID: 25367100
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modeling and prediction of subject accrual and event times in clinical trials: a systematic review.
    Zhang X; Long Q
    Clin Trials; 2012 Dec; 9(6):681-8. PubMed ID: 22674642
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Joint monitoring and prediction of accrual and event times in clinical trials.
    Zhang X; Long Q
    Biom J; 2012 Nov; 54(6):735-49. PubMed ID: 22907686
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stochastic modeling and prediction for accrual in clinical trials.
    Zhang X; Long Q
    Stat Med; 2010 Mar; 29(6):649-58. PubMed ID: 20082363
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preliminary evaluation of factors associated with premature trial closure and feasibility of accrual benchmarks in phase III oncology trials.
    Schroen AT; Petroni GR; Wang H; Gray R; Wang XF; Cronin W; Sargent DJ; Benedetti J; Wickerham DL; Djulbegovic B; Slingluff CL
    Clin Trials; 2010 Aug; 7(4):312-21. PubMed ID: 20595245
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Challenges to accrual predictions to phase III cancer clinical trials: a survey of study chairs and lead statisticians of 248 NCI-sponsored trials.
    Schroen AT; Petroni GR; Wang H; Thielen MJ; Sargent D; Benedetti JK; Cronin WM; Wickerham DL; Wang XF; Gray R; Cohn WF; Slingluff CL; Djulbegovic B
    Clin Trials; 2011 Oct; 8(5):591-600. PubMed ID: 21878447
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bayesian interim analysis in clinical trials.
    Zhang X; Cutter G
    Contemp Clin Trials; 2008 Sep; 29(5):751-5. PubMed ID: 18589003
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bayesian randomized clinical trials: From fixed to adaptive design.
    Yin G; Lam CK; Shi H
    Contemp Clin Trials; 2017 Aug; 59():77-86. PubMed ID: 28455232
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Statistical modeling and prediction of clinical trial recruitment.
    Lan Y; Tang G; Heitjan DF
    Stat Med; 2019 Mar; 38(6):945-955. PubMed ID: 30411375
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Simple Bayesian analysis in clinical trials: a tutorial.
    Abrams K; Ashby D; Errington D
    Control Clin Trials; 1994 Oct; 15(5):349-59. PubMed ID: 8001356
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Accrual by groups in trials with discrete-time survival endpoints.
    Jóźwiak K; Moerbeek M
    Clin Trials; 2013 Feb; 10(1):32-42. PubMed ID: 23203992
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bayesian design using adult data to augment pediatric trials.
    Schoenfeld DA; Hui Zheng ; Finkelstein DM
    Clin Trials; 2009 Aug; 6(4):297-304. PubMed ID: 19667026
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interim recruitment prediction for multi-center clinical trials.
    Urbas S; Sherlock C; Metcalfe P
    Biostatistics; 2022 Apr; 23(2):485-506. PubMed ID: 32978616
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predicting Low Accrual in the National Cancer Institute's Cooperative Group Clinical Trials.
    Bennette CS; Ramsey SD; McDermott CL; Carlson JJ; Basu A; Veenstra DL
    J Natl Cancer Inst; 2016 Feb; 108(2):. PubMed ID: 26714555
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.